Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 1Leukemia 1

Interventions

Gene Expression Profiling 11Surveys and Questionnaires 9Polymerase Chain Reaction 9Immunohistochemistry 9Amplified Fragment Length Polymorphism Analysis 9Flow Cytometry 8Psychiatric Rehabilitation 7Microarray Analysis 6Rituximab 5Interviews as Topic 4Cytogenetic Analysis 4Blood Specimen Collection 4Biopsy 4Therapeutics 3Immunologic Techniques 3Gene Rearrangement 3Drug Therapy 3Doxorubicin 3Data Collection 3Cyclophosphamide 3plerixafor 2Vincristine 2Prednisone 2Positron-Emission Tomography 2Phlebotomy 2Pharmacogenomic Testing 2Observation 2Neuropsychological Tests 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Lymphoma × Loratadine × Clear all
NCT02305979 2018-07-03

Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies

Wake Forest University Health Sciences

Completed
61 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡